| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
23,932 |
20,921 |
$1.70M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
7,894 |
7,288 |
$841K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
5,852 |
5,687 |
$737K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
4,705 |
4,507 |
$538K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
3,998 |
3,872 |
$455K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
2,314 |
2,267 |
$287K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
12,353 |
11,749 |
$239K |
| 90461 |
|
6,943 |
6,648 |
$92K |
| 99383 |
|
569 |
549 |
$77K |
| 92552 |
|
7,337 |
7,080 |
$76K |
| 99381 |
|
764 |
677 |
$69K |
| 99384 |
|
260 |
259 |
$40K |
| 90671 |
|
726 |
705 |
$37K |
| 99382 |
|
260 |
247 |
$36K |
| 87428 |
|
810 |
775 |
$28K |
| 90670 |
|
2,678 |
2,598 |
$26K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
4,064 |
3,854 |
$25K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
222 |
221 |
$23K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
2,965 |
2,817 |
$14K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
344 |
323 |
$11K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
1,663 |
911 |
$9K |
| 90651 |
|
1,010 |
974 |
$8K |
| 90681 |
|
1,336 |
1,283 |
$7K |
| 90716 |
|
1,896 |
1,809 |
$4K |
| 90698 |
|
2,507 |
2,423 |
$3K |
| 0071A |
|
79 |
70 |
$2K |
| 90633 |
|
2,241 |
2,178 |
$2K |
| 90661 |
|
73 |
71 |
$2K |
| 83655 |
|
560 |
541 |
$2K |
| 99173 |
|
8,507 |
7,582 |
$2K |
| 90619 |
|
164 |
161 |
$2K |
| 0072A |
|
56 |
43 |
$2K |
| 90620 |
|
212 |
209 |
$2K |
| 90707 |
|
1,900 |
1,817 |
$2K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
174 |
112 |
$1K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
600 |
581 |
$1K |
| 90686 |
|
1,629 |
1,571 |
$1K |
| 36416 |
|
606 |
588 |
$932.12 |
| 90734 |
|
521 |
500 |
$842.42 |
| 90744 |
|
1,396 |
1,315 |
$715.12 |
| 0001A |
|
25 |
25 |
$701.27 |
| 85018 |
|
791 |
764 |
$641.07 |
| 90700 |
|
459 |
422 |
$476.56 |
| 0002A |
|
19 |
19 |
$464.84 |
| 90674 |
|
105 |
97 |
$439.02 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
510 |
494 |
$301.90 |
| 90696 |
|
378 |
366 |
$282.36 |
| 96127 |
|
297 |
286 |
$180.09 |
| 87631 |
|
123 |
121 |
$125.99 |
| 90715 |
|
411 |
397 |
$96.02 |
| 90647 |
|
494 |
474 |
$70.17 |
| 99072 |
|
158 |
153 |
$48.01 |
| 90688 |
|
44 |
43 |
$40.83 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
28 |
12 |
$28.00 |
| 90713 |
|
195 |
180 |
$24.01 |
| 81003 |
|
97 |
96 |
$17.24 |
| 90648 |
|
170 |
167 |
$11.56 |
| 90723 |
|
551 |
530 |
$0.00 |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
127 |
125 |
$0.00 |